The Fenway Institute赞助的临床试验
总计5034个结果
-
The Netherlands Cancer InstituteBristol-Myers Squibb完全的
-
The Methodist Hospital Research InstituteVeloxis Pharmaceuticals撤销肾移植急性排斥反应 | 肾脏疾病,终末期 | 供体特异性抗体
-
The Netherlands Cancer InstituteDutch Cancer Society完全的
-
The Netherlands Cancer InstituteAstraZeneca; Boehringer Ingelheim未知
-
The Cleveland ClinicNational Cancer Institute (NCI)终止
-
The Methodist Hospital Research InstituteNovartis Pharmaceuticals完全的
-
The Methodist Hospital Research InstituteOxford BioMedica终止
-
The Methodist Hospital Research InstituteGenentech, Inc.终止
-
The Methodist Hospital Research InstituteOxford BioMedica完全的
-
The Miriam HospitalNational Cancer Institute (NCI)完全的
-
The Cleveland Clinic未知
-
National Cancer Institute (NCI)The Cleveland Clinic完全的
-
The Cleveland ClinicNational Cancer Institute (NCI)完全的乳腺癌 | 遗传性乳腺癌/卵巢癌(brca1、brca2)
-
The Netherlands Cancer InstituteDutch Cancer Society未知因治疗引起的主诉的乳腺癌患者的更年期症状
-
The Netherlands Cancer InstituteHoffmann-La Roche尚未招聘
-
The Netherlands Cancer InstituteDaiichi Sankyo, Inc.尚未招聘表皮生长因子受体基因突变 | 非小细胞肺癌 | 晚期非小细胞鳞状肺癌
-
Ottawa Hospital Research InstituteThe Ottawa Hospital尚未招聘
-
The Aurum Institute NPCJohns Hopkins University招聘中结核 | 艾滋病毒血清阳性 | 家庭联系方式南非, 印度, 印度尼西亚, 莫桑比克
-
The Netherlands Cancer InstituteHoffmann-La Roche招聘中
-
Hellenic Institute for the Study of Sepsis主动,不招人
-
The Rogosin InstituteJanssen Research & Development, LLC完全的
-
Hellenic Institute for the Study of Sepsis完全的
-
The Netherlands Cancer InstituteBristol-Myers Squibb主动,不招人
-
Hellenic Institute for the Study of Sepsis完全的
-
The Netherlands Cancer InstituteBristol-Myers Squibb主动,不招人
-
The Netherlands Cancer InstituteRoche Pharma AG完全的
-
Hellenic Institute for the Study of Sepsis完全的